Skip to content

The influence of the timing selection method using the "Midnight Flow Inflow" technique and auricular acupressure on patients with chemotherapy-related constipation of the lung cancer with qi and blood deficiency syndrome

The influence of the timing selection method using the "Midnight Flow Inflow" technique and auricular acupressure on patients with chemotherapy-related constipation of the lung cancer with qi and blood deficiency syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119009
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-18
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation related to chemotherapy in the case of lung cancer with deficiency of qi and blood

Interventions

Experimental group:Regular care combined with the timing-based insertion of subdiaphragmatic acupoints and ear acupressure using the "Nasal Insertion Method"
Control group:Regular care + auricular point pressing

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 - 75 years old; 2.Gender and ethnicity are not restricted; 3. Meet the Western medical diagnosis of lung cancer; 4. Meet the diagnostic criteria for constipation and syndromes in both Western and Chinese medicine after using chemotherapy drugs; 5. Bowel movements were normal before chemotherapy and there was no habitual constipation in daily life; 6. Karnofsky Performance Status Score (KPS) >= 60 points; 7. Ears are intact and undamaged, allowing for auricular acupressure; 8. Conscious and willing to participate in this study. Note: Only patients meeting all 7 of the above criteria can be included in this study.

Exclusion criteria

Exclusion criteria: 1. Patients who have been taking drugs that affect intestinal function for a long time; 2. Patients with a history of digestive tract surgeries, intestinal obstruction, digestive tract bleeding and other intestinal diseases; 3. Patients with severe primary diseases such as cardiovascular diseases (such as coronary heart disease, heart failure), liver diseases (such as liver cirrhosis, liver cancer), kidney diseases (such as chronic renal failure, nephrotic syndrome), digestive diseases (such as gastric cancer, severe acute pancreatitis), hematological diseases (such as leukemia, aplastic anemia), or other tumors; 4. Lactating women and those who have a pregnancy plan within the next three months; 5. Patients currently participating in other drug trials; 6. Patients allergic to adhesive tapes or alcohol; 7. Patients with severe infections. Note: All patients who meet any of the above conditions will be excluded.

Design outcomes

Primary

MeasureTime frame
The average number of spontaneous complete defecations per week;

Secondary

MeasureTime frame
Anxiety and depression score;Score for the main symptoms of constipation;The first time of defecation;Evaluation of Therapeutic Effects of Traditional Chinese Medicine Syndromes;Quality of life;

Countries

China

Contacts

Public ContactChen Lingxuan

The First Affiliated Hospital of Xiamen University

150072373@qq.com+86 10 1234 5678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026